Restricted accessResearch articleFirst published online 2011-9
Linkage of Some Trace Elements,Peripheral Blood Lymphocytes,Inflammation,and Oxidative Stress in Patients Undergoing Either Hemodialysis or Peritoneal Dialysis
Changes in essential trace elements may affect the inflammatory and immunological state of patients on hemodialysis (HD) or peritoneal dialysis (PD). Therefore, we aimed to determine trace element content and markers of oxidative stress, inflammation, and immune status in HD and PD patients and to assess the relationships among these parameters.
Methods
Patients on either HD (n = 20) or PD (n = 20) and age-, sex-, body mass index-matched healthy individuals (n = 20) were enrolled in the study. The trace elements zinc, copper, selenium, and iron; markers of oxidative stress thiobarbituric acid reactive substances (TBARS) and protein carbonyl levels; activities of antioxidant enzymes superoxide dismutase (SOD), glutathione peroxidase (GPx), and catalase; percentages of CD3 T lymphocytes and the subsets CD4 and CD8; the CD4/CD8 ratio; and C-reactive protein (CRP) were measured.
Results
All dialysis patients had low levels of albumin and hemoglobin. Significantly decreased percentages of CD3 and CD4 T lymphocytes and increased levels of CRP, TBARS, and carbonyl compounds were observed in HD patients. HD patients also had elevated erythrocyte SOD, lower GPx and catalase activities, and decreased levels of Se, Zn, and Fe in comparison to PD patients and healthy subjects. In addition, CRP was positively associated with TBARS and carbonyl levels, but was significantly inversely associated with Zn and Se levels. Positive correlations were found between T lymphocyte CD3 and CD4 percentages and Zn, Se, and Fe levels.
Conclusions
There were significant decreases in T lymphocyte-related immunological regulation and increased inflammation and oxidative stress in dialysis patients. Essential trace element status was independently related to immune status, inflammation, and oxidative damage.
ReikesS.T.Trends in end-stage renal disease: epidemiology, morbidity and mortality.Postgrad Med2000; 108: 124–6, 129–31, 135–6.
2.
LucchiL., BergaminiS., IannoneA., PerroneS., StipoL., OlmedaF.Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments.Artif Organs2005; 29: 67–72.
3.
Al WakeelJ.S., MitwalliA.H., Al MohayaS., Abu-AishaH., TarifN., MalikG.H.Morbidity and mortality in ESRD patients on dialysis.Saudi J Kidney Dis Transpl2002; 13: 473–7.
4.
FortesP.C., VersariP.H., StinghenA.E., Pecoits-FilhoR.Controlling inflammation in peritoneal dialysis: the role of PD-related factors as potential intervention targets.Perit Dial Int2007; 27(Suppl 2): S76–81.
5.
RambodM., KovesdyC.P., Kalantar-ZadehK.Malnutrition-inflammation score for risk stratification of patients with CKD: is it the promised gold standard?Nat Clin Pract Nephrol2008; 4: 354–5.
6.
DounousiE., PapavasiliouE., MakedouA., IoannouK., KatopodisK.P., TselepisA.Oxidative stress is progressively enhanced with advancing stages of CKD.Am J Kidney Dis2006; 48: 752–60.
7.
de CalM., CruzD.N., CorradiV., NalessoF., PolancoN., LentiniP.HLA-DR expression and apoptosis: a cross-sectional controlled study in hemodialysis and peritoneal dialysis patients.Blood Purif2008; 26: 249–54.
8.
BorazanA., UstünH., UstundagY., AydemirS., BayraktarogluT., SertM.The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levels.mediators Inflamm2004; 13: 201–4.
9.
TonbulH.Z., DemirM., AltintepeL., GüneyI., YeterE., TürkS.Malnutrition-inflammation-atherosclerosis (MIA) syndrome components in hemodialysis and peritoneal dialysis patients.Ren Fail2006; 28: 287–94.
10.
TaylorJ.E., ScottN., BridgesA., HendersonI.S., StewartW.K., BelchJ.J.Lipid peroxidation and antioxidant in continuous ambulatory dialysis patients.Perit Dial Int1992; 12: 252–6.
11.
SamouilidouE.C., GrapsaE.J., KakavasI., ElghorouryE.A., El-SaaidG.S., IsmailA.A.Oxidative stress markers and C-reactive protein in end-stage renal failure patients on dialysis.Int Urol Nephrol2003; 35: 393–7.
12.
KoW.S., GuoC.H., YehM.S., LinL.Y., HsuG.S., ChenP.C.Blood micronutrient, oxidative stress, and viral load in patients with chronic hepatitis C.World J Gastroenterol2005; 11: 4697–702.
13.
FassettR.G., DriverR., HealyH., RanganathanD., RatanjeeS., RobertsonI.K.Comparison of markers of oxidative stress, inflammation and arterial stiffness between incident hemodialysis and peritoneal dialysis patients—an observational study.BMC Nephrol2009; 10: 8.
14.
VioraM., QuarantaM.G., StrafaceE., VariR., MasellaR., MalorniW.Redox imbalance and immune functions: opposite effects of oxidized low-density lipoproteins and N-acetylcysteine.Immunology2001; 104: 431–8.
15.
DursunE., DursunB., SüleymanlarG., OzbenT.Carbonyl stress in chronic renal failure: the effect of haemodialysis.Ann Clin Biochem2005; 42(pt 1): 64–6.
16.
CoskunC., KuralA., DöventasY., KoldasM., OzturkH., InalB.B.Hemodialysis and protein oxidation products.Ann N Y Acad Sci2007; 1100: 404–8.
17.
GuoC.H., KoW.S., ChenP.C., HsuG.S., LinC.Y., WangC.L.Alterations of trace elements and oxidative stress in uremic patients with dementia.Biol Trace Elem Res2009; 131: 13–24.
18.
PagliaD., ValentineW.N.Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase.J lab Clin Med1967; 70: 158–69.
19.
EdefontiA., MastrangeloA., PaglialongaF.Assessment and monitoring of nutrition status in pediatric peritoneal dialysis patients.Perit Dial Int2009; 29(Suppl 2): S176–9.
20.
SpiegelD.M., RaggiP., SmitsG., BlockG.A.Factors associated with mortality in patients new to haemodialysis.Nephrol Dial Transplant2007; 22: 3568–72.
21.
SayarliogluH., ErkocR., DemirC., DoganE., SayarliogluM., OnerA.F.Nutritional status and immune functions in maintenance hemodialysis patients.mediators Inflamm2006; 202: 64–7.
22.
NasriH.Serum C-reactive protein (CRP) in association with various nutritional parameters in maintenance hemodialysis patients.Bratisl Lek Listy2005; 106: 390–5.
23.
DanielskiM., IkizlerT.A., McMonagleE., KaneJ.C., PupimL., MorrowJ.Linkage of hypo-albuminemia, inflammation, and oxidative stress in patients receiving maintenance hemodialysis therapy.Am J Kidney Dis2003; 42: 286–94.
24.
GriveasI., DorotheaP., AlexandraF., GeorgeV., PavlitouA., SakellariouG.Comparison of blood and peritoneal lymphocytes from continuous ambulatory peritoneal dialysis patients, asymptomatic and with peritonitis.Ren Fail2006; 28: 237–9.
25.
OzdemirE., St JohnL.S., GillespieG., YujiK., KusumiE., HoriA.Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigen-specific CD8+ T cells.Blood2002; 100: 3690–7.
26.
SchollmeyerP., BozkurtF.The immune status of the uremic patient: hemodialysis vs CAPD.Clin Nephrol1988; 30(Suppl 1): S37–40.
27.
GrzegorzewskaA.E., LeanderM.Lymphocyte subsets in the course of continuous ambulatory peritoneal dialysis.Adv Perit Dial2001; 17: 10–14.
28.
MagginiS., WintergerstE.S., BeveridgeS., HornigD.H.Selected vitamins and trace elements support immune function by strengthening epithelial barriers and cellular and humoral immune responses.Br J Nutr2007; 98(Suppl 1): S29–35.
29.
PrasadA.S.Zinc: mechanisms of host defense.J Nutr2007; 137: 1345–9.
30.
GrimbleR.F.Nutritional modulation of immune function.Proc Nutr Soc2001; 60: 389–97.
31.
SahinH., UyanikF., InançN., ErdemO.Serum zinc, plasma ghrelin, leptin levels, selected biochemical parameters and nutritional status in malnourished hemodialysis patients.Biol Trace Elem Res2009; 127: 191–9.
32.
Navarro-AlarconM., Reyes-PérezA., Lopez-GarciaH., Palomares-BayoM., Olalla-HerreraM., Lopez-MartinezM.C.Longitudinal study of serum zinc and copper levels in hemodialysis patients and their relation to biochemical markers.Biol Trace Elem Res2006; 113: 209–22.
33.
TsouchnikasI., TsilipakouM., DaniilidisM., KyriazisG., PasadakisP., ParapanissiouE.Effect of iron loading on peripheral blood lymphocyte subsets and on circulating cytokine levels in iron-depleted hemodialysis patients receiving erythropoietin.Nephron Clin Pract2007; 107: c97–102.
34.
SantonA., FormigariA., IratoP.The influence of metallothionein on exposure to metals: an in vitro study on cellular models.Toxicol In Vitro2008; 22: 980–7.
35.
PocinoM., MalavéI., BauteL.Zinc administration restores the impaired immune response observed in mice receiving excess copper by oral route.Immunopharmacol Immunotoxicol1990; 12: 697–713
36.
JungH.H., ChoiD.H., LeeS.H.Serum malondialdehyde and coronary artery disease in hemodialysis patients.Am J Nephrol2004; 24: 537–42.
37.
RutkowskiP., MalgorzewiczS., SlominskaE., RenkeM., Lysiak-SzydlowskaW., SwierczynskiJ.Interrelationship between uremic toxicity and oxidative stress.J Ren Nutr2006; 16: 190–3.
38.
MitrogianniZ., BarboutiA., GalarisD., SiamopoulosK.C.Oxidative modification of albumin in predialysis, hemodialysis, and peritoneal dialysis patients.Nephron Clin Pract2009; 113: c234–40.
39.
YooJ.H., MaengH.Y., SunY.K., KimY.A., ParkD.W., ParkT.S.Oxidative status in iron-deficiency anemia.J Clin lab Anal2009; 23: 319–23.
40.
ZwolinskaD., GrzeszczakW., SzczepanskaM., MakulskaI., Kilis-PstrusinskaK., SzpryngerK.Oxidative stress in children on peritoneal dialysis.Perit Dial Int2009; 29: 171–7.
41.
FalaknaziK., BagheriN., TazikiO.Assessment of inflammatory factors and cardiac troponin T in hemodialysis patients.Saudi J Kidney Dis Transpl2009; 20: 219–22.
42.
HauserA.B., StinghenA.E., KatoS., BucharlesS., AitaC., YuzawaY.Characteristics and causes of immune dysfunction related to uremia and dialysis.Perit Dial Int2008; 28(Suppl 3): S183–7.
43.
BayésB., PastorM.C., BonalJ., JuncàJ., HernandezJ.M., RiutortN.Homocysteine, C-reactive protein, lipid peroxidation and mortality in haemodialysis patients.Nephrol Dial Transplant2003; 18: 106–12.
44.
SundlI., RoobJ.M., MeinitzerA., TiranB., KhoschsorurG., HaditschB.Antioxidant status of patients on peritoneal dialysis: associations with inflammation and glycoxidative stress.Perit Dial Int2009; 29: 89–101.
45.
HimmelfarbJ.Relevance of oxidative pathways in the pathophysiology of chronic kidney disease.Cardiol Clin2005; 23: 319–30.
46.
BozaliogluS., OzkanY., TuranM., SimsekB.Prevalence of zinc deficiency and immune response in short-term hemodialysis.J Trace Elem Med Biol2005; 18: 243–9.
47.
BoberJ., KwiatkowskaE., KedzierskaK., OlszewskaM., GolebiewskaE., StachowskaE.Influence of glucose in the dialysate on the activity of erythrocyte-glutathione-peroxidase and blood selenium concentration in hemodialyzed patients.Arch Med Res2007; 38: 330–6.
